Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Foll...

por ter Haar, Nienke M., van Dijkhuizen, E. H. Pieter, Swart, Joost F., van Royen‐Kerkhof, Annet, el Idrissi, Ayman, Leek, Arjen P., de Jager, Wilco, de Groot, Mark C. H., Haitjema, Saskia, Holzinger, Dirk, Foell, Dirk, van Loosdregt, Jorg, Wulffraat, Nico M., de Roock, Sytze, Vastert, Sebastiaan J.
Publicado 2019